(Q47726575)

English

Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution

scientific article published on 23 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

0 references

Hojjat Ahmadzadehfar

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

object named as

Joerg Wenzel

5

0 references

author name string

Torsten Hinz

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

Anja Wierzbicki

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

Tobias Hoeller

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

Hans-J Biersack

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

Thomas Bieber

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

Monika-H Schmid-Wendtner

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

publication date

23 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

39

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

1316-1325

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

https://scigraph.springernature.com/pub.10.1007/s00259-012-2139-3

0 references

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Sentinel node biopsy for melanoma: an update after two decades of experience

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Sentinel-node biopsy or nodal observation in melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Sentinel Lymph Node Mapping for Thick (?4-mm) Melanoma: Should We Be Doing It?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

The prognosis of patients with thick primary melanomas: is regional lymph node status relevant, and does removing positive regional nodes influence outcome?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Cutaneous melanoma: prognosis and treatment results worldwide

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Sentinel lymph node status in melanoma: a valuable prognostic factor?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Cutaneous melanoma: current practice and surgical controversies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Prognosis of thick cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Prognostic information from sentinel lymph node biopsy in patients with thick melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Sentinel lymph node biopsy status is a key parameter to stratify the prognostic heterogeneity of malignant melanoma in high-risk tumors >4.0 mm.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Use of sentinel node lymphoscintigraphy in malignant melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Role of selective sentinel lymph node dissection in head and neck melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Sentinel lymph node biopsy in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2139-3

21 January 2018

Outcome of patients with melanoma and histologically negative sentinel lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical node-negative thick melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

False-negative sentinel lymph node biopsy in head and neck melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic implications of thick (>or=4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of sentinel lymph node biopsy in patients with thick (>4 mm) primary melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-012-2139-3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/22618833

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47726575&oldid=2167260304"